(((S)-5-((S)-2-(4-(((S)-2-((S)-2-amino-4-carboxybutanamido)-4-carboxybutanamido)methyl)benzamido)-3-(naphthalen-2-yl)propanamido)-1-carboxypentyl)carbamoyl)-L-glutamic acid

Catalog No. :
ACPZPA786
CAS No. :
2093321-17-4
Molecular Formula :
C43H53N7O15
Molecular Weight :
907.93

IUPAC Name:(((S)-5-((S)-2-(4-(((S)-2-((S)-2-amino-4-carboxybutanamido)-4-carboxybutanamido)methyl)benzamido)-3-(naphthalen-2-yl)propanamido)-1-carboxypentyl)carbamoyl)-L-glutamic acid

(((S)-5-((S)-2-(4-(((S)-2-((S)-2-amino-4-carboxybutanamido)-4-carboxybutanamido)methyl)benzamido)-3-(naphthalen-2-yl)propanamido)-1-carboxypentyl)carbamoyl)-L-glutamic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(((S)-5-((S)-2-(4-(((S)-2-((S)-2-amino-4-carboxybutanamido)-4-carboxybutanamido)methyl)benzamido)-3-(naphthalen-2-yl)propanamido)-1-carboxypentyl)carbamoyl)-L-glutamic acid
IUPAC Name(((S)-5-((S)-2-(4-(((S)-2-((S)-2-amino-4-carboxybutanamido)-4-carboxybutanamido)methyl)benzamido)-3-(naphthalen-2-yl)propanamido)-1-carboxypentyl)carbamoyl)-L-glutamic acid
Molecular FormulaC43H53N7O15
Molecular Weight907.93
SMILESO=C(C1=CC=C(C=C1)CNC([C@H](CCC(O)=O)NC([C@@H](N)CCC(O)=O)=O)=O)N[C@H](C(NCCCC[C@@H](C(O)=O)NC(N[C@H](C(O)=O)CCC(O)=O)=O)=O)CC2=CC3=C(C=CC=C3)C=C2
InChI KeyPKIZAQREVQFKMN-ZTTXAYQISA-N
CAS No.2093321-17-4

Synthetic Route by SureRoute

1. ACPZPA786 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPZPA786 route product structure diagram
    ACPZPA7862093321-17-4
Inquiry

2. ACPZPA786 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPZPA786 route product structure diagram
    ACPZPA7862093321-17-4
Inquiry

Comments (0)